Viral Hemorrhagic Disease
Viral Hemorrhagic Disease - Related Videos
08:33
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
0 Views •
Cited by 12 •
2016
This manuscript describes how viral vector-mediated local gene delivery provides an attractive way to express transgenes in the central nervous system. The protocol outlines all crucial steps to perform a viral vector injection in the substantia nigra of the rat to develop a viral vector-based animal model for Parkinson's disease.
05:13
A Viral Vector Injection into the Rat Substantia Nigra for Neurodegenerative Disease Modeling
0 Views •
2025
This video demonstrates the process of injecting a viral vector into the rat substantia nigra to model Parkinson's disease. It outlines the steps for preparing the rat, microinjecting the viral vector into the substantia nigra, and the recovery procedure.
13:45
Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
0 Views •
Cited by 84 •
2011
The Virochip is a pan-viral microarray designed to simultaneously detect all known viruses as well as novel viruses on the basis of conserved sequence homology. Here we demonstrate how to run a Virochip assay to analyze clinical samples for the presence of both known and unknown viruses.
02:29
Modeling Drug-Induced Hemorrhage in Zebrafish Larva
0 Views •
2025
In this video, fertilized zebrafish embryos are dechorionated under a stereo microscope and then exposed to a cholesterol synthesis inhibitor, leading to the development of blood vessel ruptures and brain hemorrhages in the larvae. Hemorrhagic larvae, identifiable by distinct red spots, are subsequently separated under a microscope for further analysis.
07:57
Integrated Compensatory Responses in a Human Model of Hemorrhage
0 Views •
Cited by 11 •
2016
The purpose of this protocol is to demonstrate the techniques for measuring compensatory responses to reduced central blood volume using lower body negative pressure as a noninvasive experimental model of human hemorrhage which can be used to quantify the total integration of compensatory mechanisms to blood volume deficit in humans.
FAQs
Disease progression begins when a virus replicates in susceptible cells, including immune and vascular cells. Replication can alter cellular function and stimulate inflammatory responses, linking the presence of the virus to changes in blood vessels and host defenses. Studying which cells support replication helps explain why particular tissues are affected and how viral activity contributes to severity.
Inflammatory responses can increase vascular permeability, meaning blood vessels become more permeable than normal. This change can allow fluid and blood components to move into surrounding tissues, contributing to tissue damage and bleeding. Examining this process helps researchers connect immune activation with clinical severity and identify biological targets for treatments intended to limit vascular disruption.
Severity reflects interactions among viral factors, host immunity, and tissue damage rather than a single mechanism. Viral activity can stimulate immune responses, while the strength and character of those responses may influence vascular injury and coagulation disturbances. Comparing these interactions helps biology researchers investigate why infections produce different outcomes and supports more precise disease models.
Platelet function and coagulation are important because they help maintain vascular integrity and control bleeding. Viral infection and associated inflammatory responses may impair these systems, allowing vascular damage to produce more severe hemorrhagic effects. Studying platelet and coagulation changes therefore connects molecular and cellular events with observable disease outcomes and can guide evaluation of potential treatments.
Diagnostic tests provide a way to identify infections and support investigation of disease patterns. In research and public health, diagnostic information can contribute to outbreak surveillance by clarifying where infections occur and how they change over time. These findings help connect biological study with timely infection-control strategies and guide evaluation of emerging interventions.
Research examines viral replication, susceptible host cells, immune responses, vascular effects, and coagulation disturbances to identify points where interventions may act. Vaccines aim to support protective immunity, while antiviral treatments are evaluated for their ability to limit viral activity or its consequences. Understanding these mechanisms helps organize development efforts around measurable biological outcomes.
Outbreak surveillance links individual infection data with broader public health patterns. It can help researchers follow how disease occurs across populations and assess the need for infection-control strategies. When combined with studies of viral factors, host immunity, and tissue damage, surveillance strengthens understanding of transmission-related risk and supports decisions about diagnostic, preventive, and therapeutic priorities.